Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Brexit to Affect Cost of Mr. Kipling Cakes in UK

XTALKS VITALS NEWS

Food

According to Gavin Darby, CEO of Premier Foods, the British food manufacturer has already been in talks with retailers about the impending cost increases.

Share this!

November 25, 2016 | by Sarah Hand, M.Sc.

Brexit has hit the UK’s food industry particularly hard, with the break affecting popular products like Marmite and Toblerone. Now, Premier Foods – the company behind Mr Kipling and Cadbury cakes – has said the price of their products will soon be increased, in response to the rising cost of ingredients.

According to Gavin Darby, CEO of Premier Foods, the British food manufacturer has already been in talks with retailers about the impending cost increases. Several staple ingredients – including butter, wheat and sugar – have increased in price dramatically this year, from 20 to 80 percent.

“That affects cake more than grocery products,” Darby told The Guardian. “We will have to look at it category by category ... A number of retailers have referred to justifiable and unjustifiable approaches from their suppliers. We feel by being very category-focused we will be much more justified.”

Darby also said that Premier Foods would be exploring a number of options to mitigate price hikes. Along with changing package sizes – a strategy that’s already been employed by other brands, including the Mars company, the makers of Maltesers – Premier will work to introduce more efficiency into its manufacturing and distribution systems.



“We can’t say there won’t be any price increases, there probably will be next year, but we are very much in the camp of limited increases,” said Richard Johnson, Premier Food’s corporate affairs director. Johnson went on to say that price increases will only be passed onto consumers as a “last resort.”

Premier Foods announced a 4 percent decrease in profits in the 6 months ending at the beginning of October. The company blamed the unseasonably warm weather in September for the decreased dessert sales and lower profits in the third quarter, which came in around £26.3 million.

Despite the lower-than-expected sales, Darby said that Premier Foods could still meet its annual sales target, due in part to its business being largely based within the UK. According to Darby, 89 percent of the company’s spending goes to UK suppliers, and 95 percent of its products are made in the UK.

“This challenge [from the fall in pounds sterling] is a bigger challenge for some of our competitors than Premier,” said Darby. “Many competitors produce in continental Europe and have to import finished goods, which is a much bigger issue. But we won’t underestimate the challenge.”


Keywords: Brexit, Food Industry, Food Manufacturing


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
GSK Malaria Vaccine to be Pilot Tested in Three African Countries

April 25, 2017 - Ghana, Kenya and Malawi will become the first countries to test GlaxoSmithKline’s (GSK) malaria vaccine in 2018.

Featured In: Life Science News


AbbVie Posts Late-Stage Clinical Trial Results for Chronic Hepatitis C Drug

April 24, 2017 - Patients with a traditionally challenging to treat subtype of hepatitis C may soon have a new treatment option for the chronic infection.

Featured In: Clinical Trials News


Study: Few Cardiovascular Benefits of Aspirin Therapy for Patients with Peripheral Vascular Disease

April 24, 2017 - A new study conducted by researchers at the University of Florida has found that aspirin therapy may not provide sufficient cardiovascular benefits for patients with peripheral vascular disease.

Featured In: Clinical Trials News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation

REGISTER FOR THESE WEBINARS

A Holistic Understanding of the Patient Journey Using Multiple Data Sources


Addressing the Challenges of Type II Diabetes Global Clinical Trials via Use of High Quality Laboratory Solutions


Clinical Trial Considerations in Cerebral Protection for TAVR Patients


Enabling Multi-Analyte Analysis of Lung Cancer FFPE Samples with 3D Biology™ Technology


Copyright © 2016-2017 Honeycomb Worldwide Inc.